clinical trial · NCT05513742
A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer
Metastatic Colorectal CancerColon CancerRectal CancerCTX-009
brief summary
This study is designed as an open-label, adaptive Simon Two-Stage study to evaluate the efficacy of CTX-009 in patients with metastatic colorectal cancer. A Simon Two-Stage adaptive design will enroll approximately 37 patients into Stage 1, and if criteria are met to move to Stage 2, an additional 47 patients will be enrolled.
started
Dec 8, 2022
primary completion
May 15, 2025
completion
May 15, 2025
last updated
May 6, 2026
official title
A Phase 2 Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer Who Have Received Two or Three Prior Systemic Chemotherapy Regimens
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol